Defective antipneumococcal polysaccharide antibody response in children with recurrent respiratory tract infections

L A Sanders1, G T Rijkers, W Kuis

  • 1Department of Immunology, University Hospital for Children and Youth, Het Wilhelmina Kinderziekenhuis, Utrecht, The Netherlands.

Insights

Patients with recurrent infections may have impaired immune responses to pneumococcal polysaccharides. Long-term follow-up is crucial to differentiate temporary delays from persistent defects, which can indicate developing humoral immunodeficiency.

Area of Science:

  • Immunology
  • Pediatrics
  • Infectious Diseases

Background:

  • Recurrent pyogenic infections are linked to impaired responses to polysaccharide antigens.
  • Investigated deficient pneumococcal polysaccharide responses in patients with recurrent infections.

Purpose of the Study:

  • To assess the immune response to pneumococcal polysaccharide vaccine in children with recurrent infections.
  • To identify potential underlying immunodeficiencies.

Main Methods:

  • 45 patients (1.7-17.1 years) received 23-valent pneumococcal polysaccharide vaccine.
  • Antibody levels to seven pneumococcal serotypes measured by ELISA pre- and post-vaccination.
  • Protein antigen booster immunization administered.

Main Results:

  • 14% (5/35) of patients with normal immunoglobulin levels had low antipneumococcal antibodies and failed to respond to vaccination.
  • 10 patients had diagnosed humoral immunodeficiency, with 7 failing to respond to pneumococcal vaccination.
  • Appropriate response to protein antigens was observed in patients with polysaccharide response defects.

Conclusions:

  • A defective immune response to polysaccharide antigens requires long-term follow-up.
  • Distinguishing transient maturational delay from persistent impaired response is essential.
  • Impaired polysaccharide response may precede humoral immunodeficiency disease.
Abstract

Related Concept Videos

Humoral Immune Responses01:36

Humoral Immune Responses

Overview
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Poliomyelitis01:17

Poliomyelitis

Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...